Skip to main content

Chao Lectureship: Scientific Lecture 2023

-
Location
Thorp Conference Center
Sue & Bill Gross Hall: A CIRM Institute 4th Floor
University of California, Irvine
845 Health Sciences Road, Irvine, CA 92697
Event Type

Add to Calendar: Outlook | Google | iCal

Scientific Lecture: Pluripotent Stem Cells as a Source of Blood Cell Therapies
George Q. Daley, MD, PhD - Harvard Medical School

Free. Registration is required (Extended Deadline: Thursday, February 2, 2023).
 


About the Allen and Lee-Hwa Chao Lectureship
The Allen and Lee-Hwa Chao Lectureship in Cancer Research was established in 1999 with a gift from Allen Chao and his wife Lee-Hwa Chao. The Chao family has been generous contributors to UC Irvine and the Cancer Center over the years, with three generations of Chaos giving nearly $30 million to the campus. The lecture series provides a forum to share and discuss topics related to cancer research, prevention and treatment. Each year the lectureship hosts an internationally renowned leader in cancer research, who delivers a technical colloquium in addition to a public lecture. Both lectures are free and open to the public.

  • 10:00 a.m. Scientific Lecture: Pluripotent Stem Cells as a Source of Blood Cell Therapies

    The Scientific Lecture is free to attend. Registration is required. Deadline to register is Friday, January 27, 2023.

Featured


George Q. Daley, MD, PhD
George Q. Daley, MD, PhD
  • Dean, Harvard Medical School
  • Caroline Shields Walker Professor of Medicine
  • Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Daley is the dean of Harvard Medical School (HMS) and the Caroline Shields Walker Professor of Medicine. A physician-scientist and an authority on stem cell science and cancer biology, his discoveries have twice been cited in Science magazine’s Top 10 Breakthroughs of the Year.

 

He has co-authored international guidelines for the conduct and clinical translation of stem cell research and regenerative medicine and for ethical oversight of emerging biotechnologies. Daley’s priorities as dean of HMS include fostering innovative biomedical, computational and health care policy research, building a pipeline of novel therapeutics founded on basic science, nurturing the next generation of physician-scientists and advancing diversity in science, technology, engineering and medicine.

 

Daley earned his AB and MD degrees from Harvard  and a PHD in biology from MIT, and has worked as a trainee, fellow and staff physician at several HMS affiliated hospitals.